The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities.
Ontology highlight
ABSTRACT: Multiple myeloma (MM) is a plasma cell malignancy of the bone marrow. Despite therapeutic advances, MM remains incurable, and better risk stratification as well as new therapies are therefore highly needed. The proteome of MM has not been systematically assessed before and holds the potential to uncover insight into disease biology and improved prognostication in addition to genetic and transcriptomic studies. Here we provide a comprehensive multiomics analysis including deep tandem mass tag-based quantitative global (phospho)proteomics, RNA sequencing, and nanopore DNA sequencing of 138 primary patient-derived plasma cell malignancies encompassing treatment-naive MM, plasma cell leukemia and the premalignancy monoclonal gammopathy of undetermined significance, as well as healthy controls.
SUBMITTER: Ramberger E
PROVIDER: S-EPMC11358022 | biostudies-literature | 2024 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA